Cencora, Inc. logo
Cencora, Inc. (COR)
Compare

Cencora, Inc. (COR) Earnings Yield: 4.63%

Is Cencora, Inc.’s earnings yield high or low?

Cencora, Inc.'s earnings yield of 4.63% is 11% above its 5-year average of 4.16%, around the middle of its 5-year range (2.12%–6.48%).

As of Saturday, June 13, 2026. 56.43% above its 12-month average of 2.96%.

COR Earnings Yield Chart

COR Earnings Yield
4.63%+58.56% 1Y
Zoom

COR Average Earnings Yield Chart

COR Current vs Average Earnings Yield Chart

COR Earnings Yield Metrics

EARNINGS YIELD

4.63%

EARNINGS YIELD AVG TTM

2.96%

EARNINGS YIELD AVG 3Y

3.49%

EARNINGS YIELD AVG 5Y

4.16%

EARNINGS YIELD AVG 10Y

5.09%

EARNINGS YIELD AVG 15Y

4.84%

EARNINGS YIELD AVG 20Y

5.04%

CURRENT VS TTM AVG

+56.43%

CURRENT VS 3Y AVG

+32.56%

CURRENT VS 5Y AVG

+11.31%

CURRENT VS 10Y AVG

-8.98%

CURRENT VS 15Y AVG

-4.39%

CURRENT VS 20Y AVG

-8.08%

COR Competitors' Earnings Yield

NAMEMARKET CAPEARNINGS YIELDTTM3Y5Y
Cencora, Inc. (COR)$54.80B4.63%2.96%3.49%4.16%
Becton, Dickinson and Company (BDX)$52.98B2.70%3.65%3.08%3.08%
Regeneron Pharmaceuticals, Inc. (REGN)$63.06B6.70%6.22%5.12%6.37%
Humana Inc. (HUM)$45.53B2.47%4.73%4.85%4.85%
IDEXX Laboratories, Inc. (IDXX)$44.24B2.42%2.01%2.08%1.94%
Agilent Technologies, Inc. (A)$36.67B3.84%3.45%3.39%3.16%
Zoetis Inc. (ZTS)$33.36B7.58%4.76%3.53%3.08%
Centene Corporation (CNC)$32.19BN/A11.79%7.73%6.10%
Medline Inc. (MDLN)$30.96B3.30%3.20%3.20%3.20%
Cigna Corporation (CI)$78.83B7.91%7.40%5.82%6.73%

Earnings Yield vs P/E Ratio

Earnings Yield

4.63%

EPS ÷ Price

P/E Ratio

21.6

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

  • It expresses earnings relative to share price as a percentage
  • It can be compared with FCF yield and dividend yield
  • It can be compared with bond yields because both are percentages
  • It is mathematically the inverse of the P/E ratio

Cencora, Inc. Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Cencora, Inc. Earnings Yield FAQ

What is the earnings yield for Cencora, Inc. (COR)?
The earnings yield for COR stock is 4.63%.
Is Cencora, Inc.'s earnings yield high or low?
Cencora, Inc.'s earnings yield of 4.63% is 11% above its 5-year average of 4.16%, around the middle of its 5-year range (2.12%–6.48%).
What is the TTM average earnings yield for Cencora, Inc. (COR)?
The TTM average earnings yield for COR stock is 2.96%.
What is the 3Y average earnings yield for Cencora, Inc. (COR)?
The 3Y average earnings yield for COR stock is 3.49%.
What is the 5Y average earnings yield for Cencora, Inc. (COR)?
The 5Y average earnings yield for COR stock is 4.16%.
What is the 10Y average earnings yield for Cencora, Inc. (COR)?
The 10Y average earnings yield for COR stock is 5.09%.
What is the 15Y average earnings yield for Cencora, Inc. (COR)?
The 15Y average earnings yield for COR stock is 4.84%.
What is the 20Y average earnings yield for Cencora, Inc. (COR)?
The 20Y average earnings yield for COR stock is 5.04%.

Cencora, Inc. Earnings Yield History

DATEEARNINGS YIELD
2026-06-124.63%
2026-06-114.63%
2026-06-104.64%
2026-06-094.66%
2026-06-084.76%
2026-06-054.74%
2026-06-044.82%
2026-06-034.95%
2026-06-024.92%
2026-06-014.93%
2026-05-294.84%
2026-05-284.87%
2026-05-274.88%
2026-05-264.81%
2026-05-224.74%
2026-05-214.91%
2026-05-204.93%
2026-05-194.90%
2026-05-184.98%
2026-05-155.06%
2026-05-145.00%
2026-05-135.10%
2026-05-125.00%
2026-05-115.02%
2026-05-085.00%
2026-05-075.10%
2026-05-065.16%
2026-05-052.72%
2026-05-042.74%
2026-05-012.74%
2026-04-302.70%
2026-04-292.67%
2026-04-282.67%
2026-04-272.68%
2026-04-242.70%
2026-04-232.67%
2026-04-222.70%
2026-04-212.66%
2026-04-202.58%
2026-04-172.54%
2026-04-162.58%
2026-04-152.62%
2026-04-142.60%
2026-04-132.61%
2026-04-102.59%
2026-04-092.58%
2026-04-082.56%
2026-04-072.59%
2026-04-062.59%
2026-04-022.56%
2026-04-012.62%
2026-03-312.65%
2026-03-302.68%
2026-03-272.66%
2026-03-262.62%
2026-03-252.56%
2026-03-242.54%
2026-03-232.60%
2026-03-202.55%
2026-03-192.51%
2026-03-182.56%
2026-03-172.49%
2026-03-162.41%
2026-03-132.38%
2026-03-122.36%
2026-03-112.38%
2026-03-102.36%
2026-03-092.30%
2026-03-062.32%
2026-03-052.32%
2026-03-042.26%
2026-03-032.24%
2026-03-022.23%
2026-02-272.24%
2026-02-262.27%
2026-02-252.29%
2026-02-242.28%
2026-02-232.27%
2026-02-202.30%
2026-02-192.32%
2026-02-182.31%
2026-02-172.31%
2026-02-132.31%
2026-02-122.37%
2026-02-112.28%
2026-02-102.31%
2026-02-092.29%
2026-02-062.32%
2026-02-052.36%
2026-02-042.52%
2026-02-032.20%
2026-02-022.19%
2026-01-302.21%
2026-01-292.26%
2026-01-282.27%
2026-01-272.23%
2026-01-262.24%
2026-01-232.25%
2026-01-222.26%
2026-01-212.26%
2026-01-202.27%
2026-01-162.24%
2026-01-152.24%
2026-01-142.27%
2026-01-132.30%
2026-01-122.32%
2026-01-092.37%
2026-01-082.37%
2026-01-072.34%
2026-01-062.30%
2026-01-052.33%
2026-01-022.35%
2025-12-312.35%
2025-12-302.34%
2025-12-292.34%
2025-12-262.33%
2025-12-242.34%
2025-12-232.33%
2025-12-222.34%
2025-12-192.33%
2025-12-182.33%
2025-12-172.32%
2025-12-162.33%
2025-12-152.27%
2025-12-122.30%
2025-12-112.31%
2025-12-102.33%
2025-12-092.36%
2025-12-082.35%
2025-12-052.34%
2025-12-042.35%
2025-12-032.37%
2025-12-022.27%
2025-12-012.21%
2025-11-282.15%
2025-11-262.16%
2025-11-252.12%
2025-11-242.61%
2025-11-212.66%
2025-11-202.68%
2025-11-192.69%
2025-11-182.69%
2025-11-172.66%
2025-11-142.68%
2025-11-132.66%
2025-11-122.67%
2025-11-112.66%
2025-11-102.66%
2025-11-072.69%
2025-11-062.70%
2025-11-052.74%
2025-11-042.82%
2025-11-032.85%
2025-10-312.88%
2025-10-302.85%
2025-10-292.92%
2025-10-282.90%
2025-10-272.89%
2025-10-242.92%
2025-10-232.96%
2025-10-222.94%
2025-10-212.96%
2025-10-202.97%
2025-10-172.99%
2025-10-163.04%
2025-10-153.04%
2025-10-143.06%
2025-10-133.07%
2025-10-103.06%
2025-10-093.09%
2025-10-083.13%
2025-10-073.15%
2025-10-063.18%
2025-10-033.21%
2025-10-023.15%
2025-10-013.12%
2025-09-303.11%
2025-09-293.15%
2025-09-263.17%
2025-09-253.25%
2025-09-243.15%
2025-09-233.21%
2025-09-223.36%
2025-09-193.35%
2025-09-183.34%
2025-09-173.36%
2025-09-163.35%
2025-09-153.33%
2025-09-123.21%
2025-09-113.21%
2025-09-103.28%
2025-09-093.25%
2025-09-083.26%
2025-09-053.32%
2025-09-043.32%
2025-09-033.29%
2025-09-023.30%
2025-08-293.33%
2025-08-283.35%
2025-08-273.34%
2025-08-263.35%
2025-08-253.37%
2025-08-223.32%
2025-08-213.20%
2025-08-203.20%
2025-08-193.30%
2025-08-183.35%
2025-08-153.32%
2025-08-143.29%
2025-08-133.34%
2025-08-123.36%
2025-08-113.34%
2025-08-083.41%
2025-08-073.49%
2025-08-063.42%
2025-08-052.95%
2025-08-042.93%
2025-08-012.99%
2025-07-313.01%
2025-07-302.95%
2025-07-292.97%
2025-07-283.01%
2025-07-252.97%
2025-07-242.97%
2025-07-232.94%
2025-07-222.94%
2025-07-212.94%
2025-07-182.94%
2025-07-172.93%
2025-07-162.89%
2025-07-152.92%
2025-07-142.90%
2025-07-112.92%
2025-07-102.90%
2025-07-092.87%
2025-07-082.89%
2025-07-072.85%
2025-07-032.91%
2025-07-022.96%
2025-07-012.92%
2025-06-302.87%
2025-06-272.88%
2025-06-262.91%
2025-06-252.95%
2025-06-242.93%
2025-06-232.94%
2025-06-202.93%
2025-06-182.90%
2025-06-172.94%
2025-06-162.95%
2025-06-132.92%
2025-06-122.92%
2025-06-113.01%
2025-06-103.03%
2025-06-093.03%
2025-06-062.98%
2025-06-052.99%
2025-06-042.98%
2025-06-032.96%
2025-06-022.95%

Showing the most recent 260 of 4,599 data points. The chart above shows the full history.

About Cencora, Inc.

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

Conshohocken, PA
47,000 employees
Healthcare / Medical - Distribution
Sector
Healthcare
Industry
Medical - Distribution
CEO
Robert Mauch